ENHABIT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.25 USD | -1.20% |
|
-1.08% | -20.29% |
| May. 14 | Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50 | MT |
| May. 10 | UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 1.08B | Sales 2025 * | 1.12B | Capitalization | 414M |
|---|---|---|---|---|---|
| Net income 2024 * | 9M | Net income 2025 * | 14M | EV / Sales 2024 * | 0.86 x |
| Net Debt 2024 * | 513M | Net Debt 2025 * | 480M | EV / Sales 2025 * | 0.8 x |
| P/E ratio 2024 * |
41.3
x | P/E ratio 2025 * |
29.3
x | Employees | 10,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.26% |
More Fundamentals
* Assessed data
More news
Latest transcript on Enhabit, Inc.
More recommendations
More press releases
| 1 day | -1.20% | ||
| 1 week | -1.08% | ||
| Current month | -18.24% | ||
| 1 month | -18.40% | ||
| 3 months | -14.86% | ||
| 6 months | -15.99% | ||
| Current year | -20.29% |
1 week
8.19
9.26
1 month
7.5510.44
Current year
7.5511.74
1 year
7.1214.59
3 years
7.1225.25
5 years
7.1225.25
10 years
7.1225.25
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 21-05-31 | |
Crissy Carlisle
DFI | Director of Finance/CFO | - | 21-05-31 |
Mark Brewer
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lee Higdon
CHM | Chairman | 77 | - |
Yvonne Curl
BRD | Director/Board Member | 69 | - |
Gregory Rush
BRD | Director/Board Member | 56 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.12% | 1,085 M€ | +8.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 8.25 | -1.20% | 739,317 |
| 24-05-16 | 8.35 | -3.58% | 697,881 |
| 24-05-15 | 8.66 | -4.20% | 654,897 |
| 24-05-14 | 9.04 | +4.63% | 1,161,836 |
| 24-05-13 | 8.64 | +3.60% | 1,105,433 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotes
Enhabit, Inc. is a provider of home health and hospice services. The Companyâs segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.
Calendar
2024-07-28
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.25
USD
Average target price
9.75
USD
Spread / Average Target
+18.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.29% | 414M | |
| -0.66% | 3.09B | |
| 0.00% | 1.97B | |
| +19.18% | 1.79B | |
| +65.37% | 692M | |
| -44.90% | 313M | |
| -21.46% | 170M | |
| -15.15% | 135M | |
| +1.92% | 67.94M |
- Stock Market
- Equities
- EHAB Stock
